Anti-inflammatory neoclerodane diterpenoids with diverse oxacyclic frameworks from Croton laui
Bioorganic Chemistry · 2026-11 · 184 · 110689
DOI: 10.1016/j.bioorg.2026.110689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Zong-Yi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, PR Ch…. Hauptthemen laut MEDLINE: Croton, Diterpenes, Clerodane, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Inflammation underlies numerous chronic diseases, and plant-derived clerodane diterpenoids have emerged as promising anti-inflammatory agents. Phytochemical investigation of the bark of Croton laui, an ethnomedicinally significant plant, afforded thirty-six previously undescribed neoclerodane diterpenoids, crolatinoids D-Z and AA-AM (1-36), together with twenty-four known analogues (37-60). Structurally, these metabolites feature a rich assortment of five- and/or six-membered oxacyclic ring systems formed through eight distinct oxygen-bridging patterns (12,20-, 17,20-, 15,16-, 19,20-, 18,19-, 6,18-, 3,19-, and 2,20-), encompassing ether, lactone, furan, hemiacetal, and acetal functionalities. Notably, compounds 1-4 possess an unprecedented 17,20-ether bridge, giving rise to a distinctive 6/6/5/5 fused heterocyclic framework. In anti-inflammatory assays, seven compounds inhibited NO production by over 50% at 20 μM, with compound 59 exhibiting the most potent activity (IC50 = 2.98 ± 0.06 μM). Mechanistic studies revealed that 59 exerts its effects through dual inhibition of the NF-κB and MAPK pathways, and its in vivo efficacy was validated in a zebrafish inflammation model. These findings substantially expand the chemical diversity of neoclerodane diterpenoids and identify 59 as a promising lead for anti-inflammatory drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, PR China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, 198 East Binhai Road, Yantai, Shandong 264117, PR China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, PR China; Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z. Y., Li, Y., Fu, R. Y., Yu, J. H., Zhao, J. X., & Yue, J. M. (2026). Anti-inflammatory neoclerodane diterpenoids with diverse oxacyclic frameworks from Croton laui. Bioorganic Chemistry, 184, 110689. https://doi.org/10.1016/j.bioorg.2026.110689
Vancouver
Zhang ZY, Li Y, Fu RY, Yu JH, Zhao JX, Yue JM. Anti-inflammatory neoclerodane diterpenoids with diverse oxacyclic frameworks from Croton laui. Bioorganic Chemistry. 2026;184:110689. doi:10.1016/j.bioorg.2026.110689
BibTeX
@article{Zhang2026,
author = {Zhang, Zong-Yi and Li, Ying and Fu, Rui-Yao and Yu, Jin-Hai and Zhao, Jin-Xin and Yue, Jian-Min},
title = {Anti-inflammatory neoclerodane diterpenoids with diverse oxacyclic frameworks from Croton laui},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {184},
pages = {110689},
doi = {10.1016/j.bioorg.2026.110689}
}
EUVIMED